Shared Decision Making With Pharmaceutical Care

Examining the Use of a Shared Decision Making Tool With Pharmaceutical Care in Type 2 Diabetes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02373059

Acronym

SDMPC

Enrollment

Registered

2015-02-26

Start date

2015-02-28

Completion date

2015-06-30

Last updated

2016-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

A research study to enhance clinical discussion between patients and pharmacists using a shared decision making tool for type 2 diabetes or usual care.

Interventions

OTHERDiabetes Issue Cards Decision Aids

OTHERUsual Pharmaceutical Care

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults ≥ 18 years of age * Diagnosed with type II diabetes by ICD-9 code for more than one year * HbA1c of 7%-9.5% within past 6 months * Prescribed three or less anti-hyperglycemic medications as indicated by the medication list within the medical record

Exclusion criteria

* Prescribed insulin * Pregnancy * Appointment with provider within a month * Appointment with provider within the last month * Followed by endocrinology

Design outcomes

Primary

Measure	Time frame
Patient Involvement Questionnaire	Post-Visit up to 2 weeks

Secondary

Measure	Time frame
Patient Knowledge regarding Diabetes treatments Questionnaire	post visit up to 2 weeks
Patient Medication Adherence Questionnaire	1 month post visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026